Published in J Virol on April 01, 2001
Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev (2006) 2.25
Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1. J Virol (2005) 1.20
A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex. J Virol (2009) 1.17
Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta. J Virol (2005) 1.16
Mechanisms of HIV-1 Nef function and intracellular signaling. J Neuroimmune Pharmacol (2011) 1.04
How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4. Elife (2014) 1.01
HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins. J Virol (2014) 0.99
Cooperative interactions of simian immunodeficiency virus Nef, AP-2, and CD3-zeta mediate the selective induction of T-cell receptor-CD3 endocytosis. J Virol (2003) 0.98
Lentiviral vectors interfering with virus-induced CD4 down-modulation potently block human immunodeficiency virus type 1 replication in primary lymphocytes. J Virol (2004) 0.90
Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase. J Virol (2009) 0.87
Single vector system for efficient N-myristoylation of recombinant proteins in E. coli. PLoS One (2010) 0.85
Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix. Retrovirology (2012) 0.85
Detection of human immunodeficiency virus type 1 Nef and CD4 physical interaction in living human cells by using bioluminescence resonance energy transfer. J Virol (2005) 0.85
Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins. PLoS One (2012) 0.80
Alkylating HIV-1 Nef - a potential way of HIV intervention. AIDS Res Ther (2010) 0.78
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses (2016) 0.77
Structure determination of human Lck unique and SH3 domains by nuclear magnetic resonance spectroscopy. BMC Struct Biol (2003) 0.77
Down-modulation of primate lentiviral receptors by Nef proteins of simian immunodeficiency virus (SIV) of chimpanzees (SIVcpz) and related SIVs: implication for the evolutionary event at the emergence of SIVcpz. J Gen Virol (2015) 0.76
Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource. Database (Oxford) (2016) 0.75
The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J Biomol NMR (1995) 12.25
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature (1991) 6.79
Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell (1994) 5.92
Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell (1996) 3.88
Protein--DNA contacts in the structure of a homeodomain--DNA complex determined by nuclear magnetic resonance spectroscopy in solution. EMBO J (1990) 3.50
The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry (1996) 3.41
Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med (1993) 3.29
The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat Struct Biol (1996) 2.94
Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell (1999) 2.89
Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J (1997) 2.57
CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci U S A (1993) 2.51
Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci U S A (1998) 2.50
Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology (1996) 2.50
A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol (1998) 2.43
Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J (1997) 2.27
Interaction of the RNA-binding domain of the hnRNP C proteins with RNA. EMBO J (1992) 2.26
Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity (1998) 2.08
The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure (1997) 2.04
Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol (1993) 1.77
Interactions of HIV-1 NEF with cellular signal transducing proteins. Front Biosci (2000) 1.75
The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J Virol (1993) 1.74
Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J Biol Chem (1994) 1.68
The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity (1997) 1.61
The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. J Virol (1994) 1.60
Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology (1996) 1.56
The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology (1994) 1.49
Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis. EMBO J (1999) 1.45
Characterization of the cryptic lambdoid prophage DLP12 of Escherichia coli and overlap of the DLP12 integrase gene with the tRNA gene argU. J Bacteriol (1989) 1.42
Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc Natl Acad Sci U S A (1995) 1.37
Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology (2000) 1.33
Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology (1996) 1.22
Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J Virol (1996) 1.18
Interaction of fluorescently labeled dideoxynucleotides with HIV-1 reverse transcriptase. Biochemistry (1991) 1.16
Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology (1997) 1.14
Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation. J Gen Virol (1993) 0.98
The numerous effector functions of Nef. Arch Biochem Biophys (1999) 0.90
HIV: a new role for Nef in the spread of HIV. Curr Biol (1999) 0.89
Molecular analysis of the cytoplasmic domain of CD4: overlapping but noncompetitive requirement for lck association and down-regulation by Nef. J Immunol (1996) 0.87
Solution structure of the cytoplasmic domain of the human CD4 glycoprotein by CD and 1H NMR spectroscopy: implications for biological functions. Biochemistry (1998) 0.80
Solution Structure of the Human CD4 (403-419) Receptor Peptide. J Biomed Sci (2001) 0.80
HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med (2001) 2.70
Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur J Biochem (1995) 1.80
Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med (1999) 1.63
The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity (1997) 1.61
A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem (1995) 1.53
Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci (2001) 1.51
Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J Exp Med (2000) 1.39
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene (2006) 1.15
Functional and structural defects in HIV type 1 nef genes derived from pediatric long-term survivors. AIDS Res Hum Retroviruses (2000) 1.02
A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr Biol (2001) 1.00
Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL. Mol Med (2001) 0.97
Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide. Protein Eng Des Sel (2008) 0.96
Generation of a non-prolyl cis peptide bond in ribonuclease T1. J Mol Biol (1994) 0.88
Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity. J Virol (2001) 0.88
Structural studies on tRNA acceptor stem microhelices: exchange of the discriminator base A73 for G in human tRNALeu switches the acceptor specificity from leucine to serine possibly by decreasing the stability of the terminal G1-C72 base pair. Nucleic Acids Res (1997) 0.87
Detection of Amyloid-beta aggregates in body fluids: a suitable method for early diagnosis of Alzheimer's disease? Curr Alzheimer Res (2009) 0.84
Equine infectious anemia virus Tat is a predominantly helical protein. Eur J Biochem (1993) 0.83
Role of the Cys 2-Cys 10 disulfide bond for the structure, stability, and folding kinetics of ribonuclease T1. Protein Sci (1994) 0.81
Solution structure of human immunodeficiency virus type 1 Vpr(13-33) peptide in micelles. Eur J Biochem (2001) 0.81
Cloning, high-yield expression in Escherichia coli, and purification of biologically active HIV-1 Tat protein. Protein Expr Purif (1996) 0.81
Structural rearrangements on HIV-1 Tat (32-72) TAR complex formation. FEBS Lett (1996) 0.80
A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies. Mini Rev Med Chem (2012) 0.79
Sequence-specific 1H, 13C and 15N resonance assignments of lymphocyte specific kinase unique and SH3 domains. J Biomol NMR (2001) 0.78
Full length Vpu from HIV-1: combining molecular dynamics simulations with NMR spectroscopy. J Biomol Struct Dyn (2006) 0.78
Follicular dendritic cells in bone marrow lymphoproliferative diseases: an immunohistochemical study including a new paraffin-resistant monoclonal antibody, DR53. Histopathology (1996) 0.78
Is EIAV Tat protein a homeodomain? Science (1996) 0.77
Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases. Vet Microbiol (2013) 0.77
Biological activity and intracellular location of the Tat protein of equine infectious anemia virus. Gene (1994) 0.77
Structural model of the HIV-1 Tat(46-58)-TAR complex. J Biomol Struct Dyn (1998) 0.77
The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study. Biochem Biophys Res Commun (1997) 0.76
Amyloid formation: age-related mechanism in Creutzfeldt-Jakob disease? Rejuvenation Res (2010) 0.76
Sequence-specific 1H, 13C and 15N resonance assignments of human GABA receptor associated protein. J Biomol NMR (2001) 0.76
High-resolution structure of a membrane protein transferred from amphipol to a lipidic mesophase. J Membr Biol (2014) 0.76
Nanoparticle surface-enhanced Raman scattering of bacteriorhodopsin stabilized by amphipol A8-35. J Membr Biol (2014) 0.75
Trifluoroethanol stabilizes a helix-turn-helix motif in equine infectious-anemia-virus trans-activator protein. Eur J Biochem (1994) 0.75
The Tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription. Gene (1998) 0.75
Structure characterization of unexpected covalent O-sulfonation and ion-pairing on an extremely hydrophilic peptide with CE-MS and FT-ICR-MS. Anal Bioanal Chem (2015) 0.75
Amyloid aggregation inhibitory mechanism of arginine-rich D-peptides. Curr Med Chem (2014) 0.75
Detection of α-synuclein aggregates by fluorescence microscopy. Rejuvenation Res (2012) 0.75
[Disseminated cryptococcosis as inaugural manifestation of AIDS]. Praxis (Bern 1994) (2005) 0.75
Molecular dynamics simulation of equine infectious anemia virus Tat protein in water and in 40% trifluoroethanol. J Biomol Struct Dyn (1994) 0.75
Binding of phage-displayed HIV-1 Tat to TAR RNA in the presence of cyclin T1. J Biomed Sci (2001) 0.75
A selection system to study protein-RNA interactions: functional display of HIV-1 Tat protein on filamentous bacteriophage M13. Biochem Biophys Res Commun (1997) 0.75